Rankings
▼
Calendar
GPCR (Structure Therapeutics Inc.) Stock Financials & Earnings | Market Cap Arena
GPCR
Structure Therapeutics Inc.
Mkt Cap
$3B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$141M
EPS (TTM)
-$2.40
Free Cash Flow (TTM)
-$226M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$20M
Q2 23
$0
$0
-$26M
Q3 23
$0
$0
-$26M
Q4 23
$0
$0
-$31M
Q1 24
$0
$0
-$32M
Q2 24
$0
$0
-$33M
Q3 24
$0
$0
-$46M
Q4 24
$0
$0
-$47M
Q1 25
$0
$0
-$56M
Q2 25
$0
$0
-$70M
Q3 25
$0
$0
-$74M
Q4 25
$0
$0
$24M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$20M
-$20M
Q2 23
-$17M
-$17M
Q3 23
-$21M
-$21M
Q4 23
-$22M
-$23M
Q1 24
-$34M
-$34M
Q2 24
-$26M
-$27M
Q3 24
-$20M
-$20M
Q4 24
-$36M
-$36M
Q1 25
-$52M
-$53M
Q2 25
-$55M
-$55M
Q3 25
-$51M
-$53M
Q4 25
-$64M
-$66M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$190K
Q3 23
$820K
Q4 23
$1M
Q1 24
$162K
Q2 24
$427K
Q3 24
$685K
Q4 24
$16K
Q1 25
$314K
Q2 25
$232K
Q3 25
$2M
Q4 25
$1M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+51.7%
Q2 23
—
+86.2%
Q3 23
—
+106.0%
Q4 23
—
+139.2%
Q1 24
—
+62.9%
Q2 24
—
+28.2%
Q3 24
—
+75.3%
Q4 24
—
+51.8%
Q1 25
—
+75.9%
Q2 25
—
+111.5%
Q3 25
—
+61.0%
Q4 25
—
-151.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
—
Q2 23
$0
—
Q3 23
$2M
—
Q4 23
$2M
—
Q1 24
$3M
—
Q2 24
$4M
—
Q3 24
$6M
—
Q4 24
$6M
—
Q1 25
$6M
—
Q2 25
$8M
—
Q3 25
$7M
—
Q4 25
$8M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$13M
$7M
Q2 23
$19M
$7M
Q3 23
$18M
$9M
Q4 23
$20M
$11M
Q1 24
$21M
$11M
Q2 24
$22M
$11M
Q3 24
$33M
$13M
Q4 24
$33M
$14M
Q1 25
$43M
$13M
Q2 25
$55M
$16M
Q3 25
$59M
$15M
Q4 25
$69M
$18M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$126M
$114M
$241M
Q2 23
$41M
$184M
$225M
Q3 23
$51M
$155M
$205M
Q4 23
$130M
$338M
$467M
Q1 24
$98M
$339M
$436M
Q2 24
$382M
$545M
$927M
Q3 24
$172M
$743M
$915M
Q4 24
$170M
$714M
$884M
Q1 25
$152M
$685M
$837M
Q2 25
$147M
$639M
$786M
Q3 25
$103M
$696M
$799M
Q4 25
$800M
$647M
$1.4B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
37M
+2.3%
Q2 23
38M
+2.2%
Q3 23
38M
+0.2%
Q4 23
46M
+21.1%
Q1 24
47M
+0.4%
Q2 24
49M
+6.1%
Q3 24
57M
+15.8%
Q4 24
57M
+0.1%
Q1 25
57M
+0.1%
Q2 25
58M
+1.0%
Q3 25
58M
+1.0%
Q4 25
59M
+1.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
—
—
FY 21
—
—
FY 22
$0
68
FY 23
$0
93
FY 24
$0
163
FY 25
$0
200K
marketcaparena.com